Reference
Sihver, W., et al., Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience 94, 685-696, (1999)
Girod, R., et al., Heteromeric complexes of α5 and/or α7 subunits. Effects of calcium and potential role in nicotine-induced presynaptic facilitation.
Ann. N.Y. Acad. Sci. 868, 578-590, (1999)
abstract
Lena, C., and Changeux, J.P., Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders.
Curr. Opin. Neurobiol. 7, 674-682, (1997)
abstract
Brioni, J.D., et al., The pharmacology of (−)-nicotine and novel cholinergic channel modulators.
Adv. Pharmacol. 37, 153-214, (1997)
abstract
Haass, M., and Kubler, W., Nicotine and sympathetic neurotransmission. Cardiovasc. Drugs Ther. 10, 657-665, (1997)
Merck
Merck 13,6551
Beilstein
Beil. 23,V,6,64
reference
Aldrich MSDS 1, 1349:A / Corp MSDS 1 (2), 2541:A / FT-IR 2 (3), 3756:D / FT-IR 1 (2), 768:B / FT-NMR 1 (3), 294:B / IR-Spectra (3), 1328:G / NMR-Reference 2 (2), 647:B / RegBook 1 (2), 2525:K / Sax 6, 1997 / Sigma FT-IR 1 (1), 596:D / Structure Index 1, 398:E:6 / Vapor Phase 3, 1537:B